AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Merck & Co., Inc. Director's Dealing 2025

May 2, 2025

284_dirs_2025-05-02_0a419aed-3a45-4356-b732-1a26cbe2b1ae.zip

Director's Dealing

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2025-04-29

Reporting Person: Romanelli Joseph (President, Human Health Int?l)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20752.545	Direct